Olopatadine hydrochloride
NDC 60505-6221, Olopatadine hydrochloride, solution/ drops, from Apotex Corp..
- Product NDC
- 60505-6221
- Status
- Listed
- Labeler
- Apotex Corp.
- Dosage form
- SOLUTION/ DROPS
- Route
- OPHTHALMIC
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA078350
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6221 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OLOPATADINE HYDROCHLORIDE1 mg/mL
Pharmacologic classes
Decreased Histamine Release [PE]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Histamine-1 Receptor Inhibitor [EPC]; Mast Cell Stabilizer [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60505-6221-0 | 60505622100 | 1 BOTTLE, PLASTIC in 1 CARTON (60505-6221-0) / 5 mL in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 60505-6221 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6221 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60505-6221. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.